Rallybio Corp (RLYB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $88.03M
Last updated: Nov 17, 2026 at 11:04 AM ET
Rallybio Corp (RLYB) Stock Forecast
Analysts expect Rallybio (RLYB) to earn -$5.52 per share in the fiscal year ending Dec 31, 2026. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$3.60.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$5.52
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$3.60
- EPS consensus
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$5.52 | -$5.52 to -$5.52 | 1 |
| Dec 31, 2027 | -$3.60 | -$3.60 to -$3.60 | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.61 | N/A | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$9.17.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$5.52 | -$5.40 | -$5.40 | -$9.17 | -$9.17 | N/A |
| Fiscal year ending Dec 31, 2027 | -$3.60 | -$3.60 | -$3.60 | -$3.60 | -$3.60 | N/A |
Frequently Asked Questions About RLYB
What is the RLYB stock forecast?
Consensus analyst estimates put Rallybio's EPS at -$5.52 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from RLYB next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$5.52, with estimates from -$5.52 to -$5.52 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.60, with estimates from -$3.60 to -$3.60 from 1 analyst.
How many analysts cover RLYB?
1 analyst estimates EPS for Rallybio for the fiscal year ending Dec 31, 2026.
RLYB pages: Overview, Earnings, Forecast, Financials, Competitors